N-3 Fatty Acid Rich Triglyceride Emulsions Are Neuroprotective after Cerebral Hypoxic-Ischemic Injury in Neonatal Mice

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Williams, Jill J ^a   Mayurasakorn, Korapat ^a   Vannucci, Susan J ^b   Mastropietro, Christopher ^c   Bazan, Nicolas G ^d   Ten, Vadim S ^a   Deckelbaum, Richard J ^a  

^a College of Physicians and Surgeons of Columbia University ^*  (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^d LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; GLUCOSE; ICOSAPENTAENOIC ACID; OMEGA 3 ACID ETHYL ESTER; OMEGA 3 FATTY ACID; OMEGA 3 FATTY ACID RICH TRIGLYCERIDE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING TIME; BRAIN BLOOD FLOW; BRAIN INFARCTION SIZE; CAROTID ARTERY LIGATION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; EMULSION; FEMALE; GLUCOSE BLOOD LEVEL; HYPOXIC ISCHEMIC ENCEPHALOPATHY; LASER DOPPLER FLOWMETRY; LOW DRUG DOSE; MALE; MOUSE; NEUROPROTECTION; NEWBORN; NONHUMAN; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANIMALS, NEWBORN; BLEEDING TIME; BLOOD GLUCOSE; BRAIN; BRAIN INFARCTION; CEREBROVASCULAR CIRCULATION; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; EMULSIONS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; HYPOXIA-ISCHEMIA, BRAIN; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; TIME FACTORS; TRIGLYCERIDES;

EID: 84874267114     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056233     Document Type: Article

References (53)

1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, et al. (2009) Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121: e46-e215.
2. Raju TN, Nelson KB, Ferriero D, Lynch JK, (2007) Ischemic perinatal stroke: summary of a workshop sponsored by the National Institute of Child Health and Human Development and the National Institute of Neurological Disorders and Stroke. Pediatrics 120: 609-616.
3. Callaway JK, (2001) Investigation of AM-36: a novel neuroprotective agent. Clin Exp Pharmacol Physiol 28: 913-918.
4. Legido A, Christos K, (2000) Perinatal Hypoxic Ischemic Encephalopathy: Current and Future Treatments. International Pediatrics 15: 143-151.
5. Mayurasakorn K, Williams JJ, Ten VS, Deckelbaum RJ, (2011) Docosahexaenoic acid: brain accretion and roles in neuroprotection after brain hypoxia and ischemia. Curr Opin Clin Nutr Metab Care 14: 158-167.
6. Calder PC, (2010) Omega-3 fatty acids and inflammatory processes. Nutrients 2: 355-374.
7. Deckelbaum RJ, Worgall TS, Seo T, (2006) n-3 fatty acids and gene expression. Am J Clin Nutr 83: 1520S-1525S.
8. Seo T, Blaner WS, Deckelbaum RJ, (2005) Omega-3 fatty acids: molecular approaches to optimal biological outcomes. Curr Opin Lipidol 16: 11-18.
9. Bazan NG, Molina MF, Gordon WC, (2011) Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases. Annu Rev Nutr 31: 321-351.
10. Perlman JM, (2007) Pathogenesis of hypoxic-ischemic brain injury. Journal of Perinatology 27: S39-S46.
11. Belayev L, Marcheselli VL, Khoutorova L, Rodriguez de Turco EB, Busto R, et al. (2005) Docosahexaenoic acid complexed to albumin elicits high-grade ischemic neuroprotection. Stroke 36: 118-123.
12. Singh AK, Yoshida Y, Garvin AJ, Singh I, (1989) Effect of fatty acids and their derivatives on mitochondrial structures. J Exp Pathol 4: 9-15.
13. Oliveira FL, Rumsey SC, Schlotzer E, Hansen I, Carpentier YA, et al. (1997) Triglyceride hydrolysis of soy oil vs fish oil emulsions. JPEN J Parenter Enteral Nutr 21: 224-229.
14. Adolph M, (1999) Lipid emulsions in parenteral nutrition. Ann Nutr Metab 43: 1-13.
15. Vannucci SJ, Hagberg H, (2004) Hypoxia-ischemia in the immature brain. J Exp Biol 207: 3149-3154.
16. Pavlakis SG, Hirtz DG, DeVeber G, (2006) Pediatric stroke: Opportunities and challenges in planning clinical trials. Pediatr Neurol 34: 433-435.
17. Ten VS, Bradley-Moore M, Gingrich JA, Stark RI, Pinsky DJ, (2003) Brain injury and neurofunctional deficit in neonatal mice with hypoxic-ischemic encephalopathy. Behav Brain Res 145: 209-219.
18. Qi K, Seo T, Al-Haideri M, Worgall TS, Vogel T, et al. (2002) Omega-3 triglycerides modify blood clearance and tissue targeting pathways of lipid emulsions. Biochemistry 41: 3119-3127.
19. Qi K, Al-Haideri M, Seo T, Carpentier YA, Deckelbaum RJ, (2003) Effects of particle size on blood clearance and tissue uptake of lipid emulsions with different triglyceride compositions. JPEN J Parenter Enteral Nutr 27: 58-64.
20. Granot E, Schwiegelshohn B, Tabas I, Gorecki M, Vogel T, et al. (1994) Effects of particle size on cell uptake of model triglyceride-rich particles with and without apoprotein E. Biochemistry. 33: 15190-15197.
21. Schwiegelshohn B, Presley JF, Gorecki M, Vogel T, Carpentier YA, et al. (1995) Effects of apoprotein E on intracellular metabolism of model triglyceride-rich particles are distinct from effects on cell particle uptake. J Biol Chem 270: 1761-1769.
22. Liszczak TM, Hedley-Whyte ET, Adams JF, Han DH, Kolluri VS, et al. (1984) Limitations of tetrazolium salts in delineating infarcted brain. Acta Neuropathol 65: 150-157.
23. Denis C, Methia N, Frenette PS, Rayburn H, Ullman-Cullere M, et al. (1998) A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. Proc Natl Acad Sci U S A 95: 9524-9529.
24. Niatsetskaya ZV, Sosunov SA, Matsiukevich D, Utkina-Sosunova IV, Ratner VI, et al. (2012) The oxygen free radicals originating from mitochondrial complex I contribute to oxidative brain injury following hypoxia-ischemia in neonatal mice. J Neurosci 32: 3235-3244.
25. Bruno A, Biller J, Adams HP Jr, Clarke WR, Woolson RF, et al. (1999) Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology 52: 280-284.
26. Caspersen CS, Sosunov A, Utkina-Sosunova I, Ratner VI, Starkov AA, et al. (2008) An isolation method for assessment of brain mitochondria function in neonatal mice with hypoxic-ischemic brain injury. Dev Neurosci 30: 319-324.
27. Berman DR, Mozurkewich E, Liu Y, Barks J (2009) Docosahexaenoic acid pretreatment confers neuroprotection in a rat model of perinatal cerebral hypoxia-ischemia. Am J Obstet Gynecol 200: 305 e301-306.
28. Williams JJ, Bazan NG, Ten VS, Vannucci SJ, Mastropietro C, et al. (2009) n-3 fatty acids are neuroprotective after cerebral hypoxia-ischemia in rodent models. FASEB J 23: 334.335 (Abstract).
29. Qi K, Seo T, Jiang Z, Carpentier YA, Deckelbaum RJ, (2006) Triglycerides in fish oil affect the blood clearance of lipid emulsions containing long- and medium-chain triglycerides in mice. J Nutr 136: 2766-2772.
30. Pan HC, Kao TK, Ou YC, Yang DY, Yen YJ, et al. (2009) Protective effect of docosahexaenoic acid against brain injury in ischemic rats. J Nutr Biochem 20: 715-725.
31. Huang J, Mocco J, Choudhri TF, Poisik A, Popilskis SJ, et al. (2000) A modified transorbital baboon model of reperfused stroke. Stroke 31: 3054-3063.
32. Mayurasakorn K, Williams JJ, Ten VS, Deckelbaum RJ (2011) n-3 but not n-6 fatty acids prevent brain death after hypoxic ischemic injury. FASEB J 25 777.710 (Abstract).
33. Grimsgaard S, Bonaa KH, Hansen JB, Nordoy A, (1997) Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. Am J Clin Nutr 66: 649-659.
34. Stanley WC, Khairallah RJ, Dabkowski ER, (2012) Update on lipids and mitochondrial function: impact of dietary n-3 polyunsaturated fatty acids. Curr Opin Clin Nutr Metab Care 15: 122-126.
35. Khairallah RJ, Sparagna GC, Khanna N, O'Shea KM, Hecker PA, et al. (2010) Dietary supplementation with docosahexaenoic acid, but not eicosapentaenoic acid, dramatically alters cardiac mitochondrial phospholipid fatty acid composition and prevents permeability transition. Biochim Biophys Acta 1797: 1555-1562.
36. Belayev L, Khoutorova L, Atkins KD, Bazan NG, (2009) Robust docosahexaenoic acid-mediated neuroprotection in a rat model of transient, focal cerebral ischemia. Stroke 40: 3121-3126.
37. Bazan NG, (2012) Neuroinflammation and Proteostasis are Modulated by Endogenously Biosynthesized Neuroprotectin D1. Mol Neurobiol 46: 221-226.
38. Marcheselli VL, Hong S, Lukiw WJ, Tian XH, Gronert K, et al. (2003) Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem 278: 43807-43817.
39. Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG, (2004) Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci U S A 101: 8491-8496.
40. Belayev L, Khoutorova L, Atkins KD, Eady TN, Hong S, et al. (2011) Docosahexaenoic Acid Therapy of Experimental Ischemic Stroke. Transl Stroke Res 2: 33-41.
41. Terpstra AH, (2001) Differences between humans and mice in efficacy of the body fat lowering effect of conjugated linoleic acid: role of metabolic rate. J Nutr 131: 2067-2068.
42. Blaxter K (1989) Energy metabolism in animals and man: Cambridge University Press, Cambridge, UK.
43. Miller AT (1986) Energy Metabolism. F.A. Davis Company, Philadelphia, PA.
44. Lewandowski C, Barsan W, (2001) Treatment of acute ischemic stroke. Ann Emerg Med 37: 202-216.
45. Blondeau N, Petrault O, Manta S, Giordanengo V, Gounon P, et al. (2007) Polyunsaturated fatty acids are cerebral vasodilators via the TREK-1 potassium channel. Circ Res 101: 176-184.
46. NINDS (1995) Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 333: 1581-1587.
47. NINDS (1997) Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke 28: 2119-2125.
48. Dirnagl U, Iadecola C, Moskowitz MA, (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22: 391-397.
49. Ten VS, Starkov A, (2012) Hypoxic-ischemic injury in the developing brain: the role of reactive oxygen species originating in mitochondria. Neurol Res Int 2012: 542976.
50. Williams JJ, Deckelbaum RJ, Mayurasakorn K, Ten VS, (2011) n-3 Fatty acids protect brain against hypoxia-ischemia (HI) by attenuation of oxidative injury and mitochondrial dysfunction FASEB J. 25: 105.104 (Abstract).
51. Lim SN, Huang W, Hall JC, Ward RE, Priestley JV, et al. (2010) The acute administration of eicosapentaenoic acid is neuroprotective after spinal cord compression injury in rats. Prostaglandins Leukot Essent Fatty Acids 83: 193-201.
52. Ward RE, Huang W, Curran OE, Priestley JV, Michael-Titus AT, (2010) Docosahexaenoic acid prevents white matter damage after spinal cord injury. J Neurotrauma 27: 1769-1780.
53. King VR, Huang WL, Dyall SC, Curran OE, Priestley JV, et al. (2006) Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. J Neurosci 26: 4672-4680.